LMR Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMR Partners's BMY Position: Q2 2026 in Review
LMR Partners increased its Bristol-Myers Squibb (BMY) stake by 6,502% in Q2 2026, buying an estimated $18.7M and bringing the position to 330,151 shares worth $19M. The position accounts for 0.07% of the portfolio, ranked #255.
LMR Partners first reported a position in BMY in Q4 2014 and has held it in 22 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- LMR Partners held 330,151 shares of Bristol-Myers Squibb worth $19M as of Q2 2026.
- LMR Partners bought 325,150 Bristol-Myers Squibb shares in Q2 2026, an estimated $18.7M.
- Bristol-Myers Squibb made up 0.07% of LMR Partners's portfolio in Q2 2026, its #255 holding.
- LMR Partners first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 22 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.